| Name | Title | Contact Details |
|---|
Interbiolab is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. With operations in North America, Latin America/Caribbean, EMEA and Asia, Ansell employs more than 15,000 people worldwide and holds leading positions in the personal protective equipment and medical gloves market, as well as in the sexual health and well-being category worldwide. Ansell operates in four main business segments: Medical, Industrial, Single Use and Sexual Wellness. Our mission is to create a world where people and products enjoy optimal protection Ansell has four main operational headquarters in Iselin, NJ, USA, Brussels, Belgium, and CyberJaya, Malaysia, and its registered office is in Melbourne, Australia. Ansell Limited is a public Australian Company with its listing on the Australian Stock Exchange (ASX:ANN).
Headquartered in Redmond, WA, Medstreaming is a leading provider of Healthcare IT (“HCIT”) solutions for image intensive specialties. We are focused on enabling proactive patient care and increasing the efficiency of healthcare by providing medical IT solutions to individual practitioners and large institutions alike. Since its founding in 2006, Medstreaming has become a market leader in delivering specialty-based workflow applications that function as a “best of breed” specialties, including, but not limited to, Cardiology, Vascular, Vein & Surgery. Lead by a team of founding engineers, clinical specialists, and healthcare IT veterans, Medstreaming is committed to dramatically improving the delivery of healthcare and disease management, while becoming a global leader developing medical informatics solutions.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.
Unlimited Visions Inc. is a La Mirada, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.